LU Profile Area: Proactive Ageing
191 – 200 of 411
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Improved Segmentation of Deep Sulci in Cortical Gray Matter Using a Deep Learning Framework Incorporating Laplace’s Equation
2023) 28th International Conference on Information Processing in Medical Imaging, IPMI 2023 In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 13939 LNCS. p.692-704(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
(
- Contribution to journal › Scientific review
-
Mark
Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis
(
- Contribution to journal › Article
-
Mark
In old men Scheuermann’s disease is not associated with neck or back pain : a Swedish cohort study
(
- Contribution to journal › Article
-
Mark
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
A pilot test of daylighting and electric lighting to address visual and non-visual requirements
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Study protocol for a feasibility study of an online educational programme for people working and living with persistent low back pain
(
- Contribution to journal › Article
-
Mark
On the micelle formation of DNAJB6b
(
- Contribution to journal › Article
-
Mark
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
(
- Contribution to journal › Article
-
Mark
Donanemab in Early Symptomatic Alzheimer Disease : The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
(
- Contribution to journal › Article